Microfactory has just completed the first part of its in vivo/in vitro correlation on antiperspirant efficiency evaluations.

The SOD4 technology characterised the efficacy of 5 antiperspirants in a single blind study. In association with a Parisian CRO, these predictions were confirmed by gravimetry, the current method of in vivo testing.

Our technology measures the pressure required to expel the clots formed during the sweat/antiperspirant contact in the microfluidic synthetic pores.

The results of the in vivo and in vitro tests are consistent, SOD4 represents a predictive and economical alternative to human antiperspirant efficacy evaluations.

 

Read the complete article: ZOOM#17 -Testing trends nails evaluation – in vitro efficacy testing – Skinobs.web

Contact

Fabrice Monti, PhD

www.microfactory.eu

11 rue Vauquelin Angle Rue Lagarde/Rue Vauquelin

75005  Paris

Tél: + 33 (0) 6 62 72 04 61

Recent Posts

Roger Guillemin: Neuroscientist who Showed How the Brain Controls Hormones via Nature

Roger Guillemin identified the molecules in the brain that control the production of hormones in…

Mitigating Multi-Source Hair Damage via Cosmetics and Toiletries

In 2007, Sinclair wrote the article “Healthy Hair: What is it?” in which he stated,…

“If things go in the Wrong Direction, it Could be a Significant Challenge to the Industry”: Cosmetics Europe director on EU Regulations

We spoke to John Chave, director-general at trade body Cosmetics Europe, about changing regulations, what’s…